Samphire Neuroscience
Founded 2021 · 12 employees on LinkedIn · 13 known investors
Find your way into Samphire Neuroscience
341 people in our graph share verified history with the Samphire Neuroscience team — schools, employers, funds. One of them is your warm intro.
Madison Lenormandunlockedknows Ervinas Bern · together at Imperial College London (overlapped)
×7knows the team · via International Baccalaureate
×4knows the team · via Imperial College London
Samphire Neuro develops brain-based neurotechnology medical devices to treat chronic pain and mood conditions in women, targeting PMDD, dysmenorrhea, perimenopause, chronic migraines, and endometriosis. Its flagship non-invasive neurostimulation headband has clearance in the UK and EU and is expanding into the United States.
Founders & leadership
Samphire Neuroscience was founded in 2021 by Emilė Radytė and Alex Cook.
ER
Emilė RadytėinCEO (Founder)Emilė Radytė is a neuroscientist and co-founder and CEO of Samphire Neuroscience, which develops neurotechnology medical devices to treat conditions including PMDD, dysmenorrhea, perimenopause, chronic migraines, and endometriosis.
AC
Alex CookinCOO (Founder)
EB
Ervinas BerninCTOErvinas Bern is CTO of Samphire Neuroscience, which develops neurostimulation medical devices for chronic pain and mood conditions. He has worked in non-invasive brain stimulation and laser science.
KC
Kendell CannonChief Medical Officer
Investors · 13
AfterWork VenturesSan Francisco · $100K – $500K
Alberts Impact VenturesSydney
Angel AcademeLondon · $11K – $385K
CVX VenturesCopenhagen · $13K – $250.6K
FirstpickVilnius · $110K – $550K
Fortify VenturesWashington · $100K – $2M
Inventure
Seaside VenturesBoulder · $250K
InventurereportedHelsinki · $330K – $5.5M
SOSVreportedNew York · $30K – $550K
Also in the syndicate · 3
AfterworkAyuhSeaside
Funding
SEC filings, press & company announcements$2.3M disclosed across 1 of 2 rounds · 2024–2025
- Undisclosed amountseed roundJun 2025Source ↗
- $2.3MPre-seedFeb 2024 · 2 sources
Afterwork, Ayuh, CVX Ventures, FIRSTPICK, Seaside, SOSV
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Competitors · 4
by search overlap
Flo Health16473 shared keywordsFlo is a women's health app offering personalized cycle tracking, fertility guidance, pregnancy support, and health education backed by a medical team. The app serves women and people with periods globally with science-based insights on hormonal health from first period to perimenopause.
Clue14830 shared keywordsClue is a menstrual and reproductive health app that lets people track their periods, cycle, ovulation, fertility, and related symptoms, and contributes anonymized data to scientific research with institutions such as Johns Hopkins and the Gates Foundation. The company offers a paid Clue Plus subscription and serves over 12 million users worldwide.
Natural Cycles11964 shared keywordsNatural Cycles offers an FDA-cleared mobile app that uses a user's body temperature data and an algorithm to predict fertile windows for hormone-free birth control and pregnancy planning. The app supports women's health across life stages from contraception through perimenopause and is certified in over 35 countries.
Ubie6026 shared keywordsUbie provides a free AI-powered symptom checker that generates a personalized report on possible causes of a user's symptoms and guidance on when to see a doctor, based on a short questionnaire developed with doctors. The consumer-facing digital health service operates in Japan, the United States, and other countries.
Companies competing with Samphire Neuroscience for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Samphire Neuroscience do?
- Samphire Neuro develops brain-based neurotechnology medical devices to treat chronic pain and mood conditions in women, targeting PMDD, dysmenorrhea, perimenopause, chronic migraines, and endometriosis. Its flagship non-invasive neurostimulation headband has clearance in the UK and EU and is expanding into the United States.
- Who founded Samphire Neuroscience?
- Samphire Neuroscience was founded by Emilė Radytė, Alex Cook in 2021.
- Who are Samphire Neuroscience's investors?
- Samphire Neuroscience's investors include AfterWork Ventures, Alberts Impact Ventures, Angel Academe, CVX Ventures, Firstpick, Fortify Ventures, Inventure, Seaside Ventures and 2 more.
- How much funding has Samphire Neuroscience raised?
- Samphire Neuroscience has disclosed $2.3M raised across 1 of its 2 known rounds.